Genes and Eye Paralysis

In patients with progressive external ophthalmoplegia (PEO), the muscles that move the eyes gradually deteriorate until the only way patients can follow an object is by turning their heads. Last year, Christine Van Broeckhoven and colleagues at the University of Antwerp, Belgium, linked PEO in a Belgian family to a point mutation in the gene for polymerase gamma, the DNA polymerase responsible for replicating the 16.5-kilobase mitochondrial chromosome.1 Now, William Copeland's lab at the Nationa

Written byTom Hollon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Polymerase gamma becomes a mutator polymerase, accelerating the accumulation of point mutations, frameshifts, and deletions in mitochondrial DNA. The steady accumulation of mutations is what accounts for the late onset and progressive nature of PEO. As a result, researchers now know that an errant DNA polymerase can cause disease.

It is unexpected news. "Polymerases are so essential, it was predicted long ago that no one would ever see natural mutations affecting fidelity," says Copeland. Reducing fidelity was presumed lethal. But if a mutator polymerase were possible, it would be a mutant polymerase gamma, Copeland believed, reasoning that the hundreds, sometimes thousands, of copies of mitochondrial DNA (mtDNA) inside cells provided a margin of safety against accumulating mutations. Even as mutator polymerases inactivated one gene after another, plenty of undamaged mitochondria would remain to permit normal cellular function.

The experiments, led by Mikhail V. Ponamarev, studied catalytic rate, binding affinity, replication ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies